Press release
Obsessive Compulsive Disorder Pipeline Analysis 2024: FDA Approvals, Clinical Trials, Therapies, Mechanism of Action, Route of Administration by DelveInsight
Obsessive Compulsive Disorder Pipeline
"Obsessive Compulsive Disorder Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Obsessive Compulsive Disorder Market.
The Obsessive Compulsive Disorder Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
Request for Sample Report here @ https://www.delveinsight.com/report-store/obsessive-compulsive-disorder-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Some of the key takeaways from the Obsessive Compulsive Disorder Pipeline Report:
• Obsessive Compulsive Disorder Companies across the globe are diligently working toward developing novel Obsessive Compulsive Disorder treatment therapies with a considerable amount of success over the years.
• Obsessive Compulsive Disorder companies working in the treatment market are Ceruvia Lifesciences, Biohaven Pharmaceuticals, Octapharma, Jazz Pharmaceuticals, Eli Lilly and Company, Spec GX (Mallinckrodt), Power Life Sciences Inc., Apotex and others, are developing therapies for the Obsessive Compulsive Disorder treatment
• Emerging Obsessive Compulsive Disorder therapies such as Troriluzole, SYNP 101, and others are expected to have a significant impact on the Obsessive Compulsive Disorder market in the coming years.
• Biohaven is working on BHV-4157, a glutamate modulator, which is currently in a Phase 2/3 clinical trial for OCD as of September 2024.
• COMPASS Pathways is conducting a Phase II clinical trial for Psilocybin (COMP360) to treat OCD, with the trial starting in February 2024.
Obsessive Compulsive Disorder Overview
Obsessive-Compulsive Disorder (OCD) is a mental health condition marked by persistent, intrusive thoughts (obsessions) and repetitive behaviors (compulsions). Individuals with OCD experience intense distress from these unwanted thoughts, which often focus on fears of contamination, harm, or symmetry. To alleviate anxiety, they may perform compulsive actions, like excessive cleaning, checking, or arranging items in a specific way. These rituals provide temporary relief but reinforce the cycle, making it difficult to stop.
OCD can range from mild to severe and interfere with daily functioning, impacting relationships, work, and personal well-being. Though the exact cause remains unclear, factors like genetics, brain structure, and environmental stressors are believed to contribute. Treatment often involves a combination of cognitive-behavioral therapy (CBT), specifically Exposure and Response Prevention (ERP), and medication like SSRIs (Selective Serotonin Reuptake Inhibitors). ERP helps individuals face their fears without performing compulsions, gradually reducing anxiety. While OCD is a chronic condition, with proper treatment, individuals can manage symptoms effectively and lead fulfilling lives. Raising awareness and reducing stigma is crucial to support those living with OCD.
Get a Free Sample PDF Report to know more about Obsessive Compulsive Disorder Pipeline Therapeutic Assessment- https://www.delveinsight.com/sample-request/obsessive-compulsive-disorder-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Obsessive Compulsive Disorder Route of Administration
Obsessive Compulsive Disorder pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
• Intra-articular
• Intraocular
• Intrathecal
• Intravenous
• Ophthalmic
• Oral
• Parenteral
• Subcutaneous
• Topical
• Transdermal
Obsessive Compulsive Disorder Molecule Type
Obsessive Compulsive Disorder Products have been categorized under various Molecule types, such as
• Oligonucleotide
• Peptide
• Small molecule
Obsessive Compulsive Disorder Pipeline Therapeutics Assessment
• Obsessive Compulsive Disorder Assessment by Product Type
• Obsessive Compulsive Disorder By Stage and Product Type
• Obsessive Compulsive Disorder Assessment by Route of Administration
• Obsessive Compulsive Disorder By Stage and Route of Administration
• Obsessive Compulsive Disorder Assessment by Molecule Type
• Obsessive Compulsive Disorder by Stage and Molecule Type
Request for Sample PDF Report for Obsessive Compulsive Disorder Pipeline Assessment and clinical trials - https://www.delveinsight.com/sample-request/obsessive-compulsive-disorder-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
DelveInsight's Obsessive Compulsive Disorder Report covers around 5+ products under different phases of clinical development like-
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration
Obsessive Compulsive Disorder Pipeline Analysis:
The Obsessive Compulsive Disorder pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Obsessive Compulsive Disorder with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Obsessive Compulsive Disorder Treatment.
• Obsessive Compulsive Disorder key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Obsessive Compulsive Disorder Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Obsessive Compulsive Disorder market.
Download Sample PDF Report to know more about Obsessive Compulsive Disorder drugs and therapies- https://www.delveinsight.com/sample-request/obsessive-compulsive-disorder-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Scope of Obsessive Compulsive Disorder Pipeline Drug Insight
• Coverage: Global
• Key Obsessive Compulsive Disorder Companies: Ceruvia Lifesciences, Biohaven Pharmaceuticals, Octapharma, Jazz Pharmaceuticals, Eli Lilly and Company, Spec GX (Mallinckrodt), Power Life Sciences Inc., Apotex and others.
• Key Obsessive Compulsive Disorder Therapies: Troriluzole, SYNP 101, and others.
• Obsessive Compulsive Disorder Therapeutic Assessment: Obsessive Compulsive Disorder current marketed and Obsessive Compulsive Disorder emerging therapies
• Obsessive Compulsive Disorder Market Dynamics: Obsessive Compulsive Disorder market drivers and Obsessive Compulsive Disorder market barriers
Further Obsessive Compulsive Disorder product details are provided in the report. Download the Obsessive Compulsive Disorder pipeline report to learn more about the emerging Obsessive Compulsive Disorder therapies- https://www.delveinsight.com/report-store/obsessive-compulsive-disorder-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Contents
1. Obsessive Compulsive Disorder Report Introduction
2. Obsessive Compulsive Disorder Executive Summary
3. Obsessive Compulsive Disorder Overview:
4. Obsessive Compulsive Disorder- Analytical Perspective In-depth Commercial Assessment
5. Obsessive Compulsive Disorder Pipeline Therapeutics
6. Obsessive Compulsive Disorder Late Stage Products (Phase II/III)
7. Obsessive Compulsive Disorder Mid Stage Products (Phase II)
8. Obsessive Compulsive Disorder Early Stage Products (Phase I)
9. Obsessive Compulsive Disorder Preclinical Stage Products
10. Obsessive Compulsive Disorder Therapeutics Assessment
11. Obsessive Compulsive Disorder Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Obsessive Compulsive Disorder Companies
14. Obsessive Compulsive Disorder Key Products
15. Obsessive Compulsive Disorder Unmet Needs
16 . Obsessive Compulsive Disorder Market Drivers and Barriers
17. Obsessive Compulsive Disorder Future Perspectives and Conclusion
18. Obsessive Compulsive Disorder Analyst Views
19. Appendix
20. About DelveInsight
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
• Anaphylaxis Market: https://www.delveinsight.com/report-store/anaphylaxis-market
• Automated External Defibrillators Market: https://www.delveinsight.com/report-store/automated-external-defibrillator-aed-market
• Hpv-induced Cancers Market: https://www.delveinsight.com/report-store/hpv-induced-cancers-market
• Non Alcoholic Fatty Liver Disease Nafld Market: https://www.delveinsight.com/report-store/nonalcoholic-steatohepatitis-nash-market
• Acute Agitation And Aggression Market: https://www.delveinsight.com/report-store/acute-agitation-and-aggression-market
• Biochips Market: https://www.delveinsight.com/report-store/biochips-market
• Alpha Antitrypsin Market: https://www.delveinsight.com/report-store/alpha-1-antitrypsin-deficiency-a1atd-market
• Pediatric Obesity Market: https://www.delveinsight.com/report-store/pediatric-obesity-market
• Carcinoid Tumor Market: https://www.delveinsight.com/report-store/carcinoid-tumor-market
• Chronic Rhinosinustis Market: https://www.delveinsight.com/report-store/chronic-rhinosinusitis-market
• Alpha-mannosidosis Market: https://www.delveinsight.com/report-store/alpha-mannosidosis-market
• Chronic Rhinosinusitis Market: https://www.delveinsight.com/report-store/chronic-rhinosinusitis-with-nasal-polyps-market
• Arteriovenous Fistula Market: https://www.delveinsight.com/report-store/arteriovenous-fistula-market
• Defibrillators Market: https://www.delveinsight.com/report-store/defibrillator-market
• Pressure Ulcers Market Size: https://www.delveinsight.com/report-store/pressure-ulcers-market
• Ophthalmic Imaging Equipment Market: https://www.delveinsight.com/report-store/ophthalmic-imaging-equipment-market
• Blood Glucose Monitoring Systems Market: https://www.delveinsight.com/report-store/blood-glucose-monitoring-systems-market
• Vascular Access Devices Market: https://www.delveinsight.com/report-store/vascular-access-device-market
• Alopecia Market: https://www.delveinsight.com/report-store/androgenetic-alopecia-market
• Dysthymia Market: https://www.delveinsight.com/report-store/major-depressive-disorder-market
• Necrotizing Enterocolitis Market: https://www.delveinsight.com/report-store/necrotizing-enterocolitis-market
• Osteoarthritis Market: https://www.delveinsight.com/report-store/knee-osteoarthritis-market
• Reactive Arthritis Market: https://www.delveinsight.com/report-store/rheumatoid-arthritis-ra-market
• Capnography Device Market: https://www.delveinsight.com/report-store/capnography-devices-market
• Gaucher Disease Market: https://www.delveinsight.com/report-store/gauchers-disease-market
• Hearing Aid Devices Market: https://www.delveinsight.com/report-store/hearing-aid-devices-market
• Central Serous Chorioretinopathy Market: https://www.delveinsight.com/report-store/central-serous-chorioretinopathy-market
• Hemophilia B Market: https://www.delveinsight.com/report-store/hemophilia-b-market
• Vitamin A Deficiency Market: https://www.delveinsight.com/report-store/vitamin-a-deficiency-market
• Acute Coronary Syndrome Market: https://www.delveinsight.com/report-store/acute-coronary-syndrome-market
• Acoustic Neuroma Market: https://www.delveinsight.com/report-store/acoustic-neuroma-market
• Pain Management Devices Market: https://www.delveinsight.com/report-store/pain-management-devices-market
• Acute Pulmonary Embolism Market: https://www.delveinsight.com/report-store/acute-pulmonary-embolism-market
• Human Papilomavirus Market: https://www.delveinsight.com/report-store/human-papillomavirus-hpv-market
• Cellulitis Market: https://www.delveinsight.com/report-store/cellulitis-market
Trending Reports:
• Artificial Iris Market: https://www.delveinsight.com/report-store/artificial-iris-market
• Biliary Stents Market: https://www.delveinsight.com/report-store/biliary-stents-market
• Biliary Tumor Market: https://www.delveinsight.com/report-store/biliary-tract-cancers-btcs-market
• Cancer Anorexia Market: https://www.delveinsight.com/report-store/cancer-anorexia-market
• Cellulitis Market: https://www.delveinsight.com/report-store/cellulitis-market
• Chemotherapy Induced Febrile Neutropenia Market: https://www.delveinsight.com/report-store/chemotherapy-induced-neutropenia-cin-market
• Chronic Inducible Urticaria Market: https://www.delveinsight.com/report-store/chronic-spontaneous-urticaria-market
• Chronic Myelogenous Leukemia Market: https://www.delveinsight.com/report-store/chronic-myelocytic-leukemia-cml-market
• Chronic Refractory Gout Market: https://www.delveinsight.com/report-store/chronic-refractory-gout-market
• Clostridium Difficile Infections Cdi Market: https://www.delveinsight.com/report-store/clostridium-difficile-infections-clostridium-difficile-associated-disease-market
• Colorectal Cancer Crc Market: https://www.delveinsight.com/report-store/metastatic-colorectal-cancer-market
• Contact Dermatitis Market: https://www.delveinsight.com/infographics/contact-dermatitis-market
• Contraceptive Devices Market: https://www.delveinsight.com/report-store/contraceptive-devices-market
• Dermal Erythema Market: https://www.delveinsight.com/report-store/dermal-erythema-market
• Eczema Market: https://www.delveinsight.com/report-store/atopic-dermatitis-market
• Ehlers-danlos Syndrome Market: https://www.delveinsight.com/report-store/ehlers-danlos-syndrome-market
• Gouty Arthritis Market: https://www.delveinsight.com/report-store/gout-market
• Hearing Implants Market: https://www.delveinsight.com/report-store/hearing-implants-market
• Hemorrhagic Cystitis Market: https://www.delveinsight.com/report-store/hemorrhagic-cystitis-market
• Hereditary Spastic Paraplegias Market: https://www.delveinsight.com/report-store/hereditary-spastic-paraplegias-market
• Higher-risk Chronic Myelomonocytic Leukemia Market: https://www.delveinsight.com/report-store/higher-risk-chronic-myelomonocytic-leukemia-market
• Hyperhidrosis Market: https://www.delveinsight.com/report-store/hyperhidrosis-market
• Hypoparathyroidism Market: https://www.delveinsight.com/report-store/hypoparathyroidism-market
• Juvenile Rheumatoid Arthritis Market: https://www.delveinsight.com/report-store/juvenile-rheumatoid-arthritis-market
• Leber's Hereditary Optic Neuropathy Market: https://www.delveinsight.com/report-store/lebers-hereditary-optic-neuropathy-lhon-market
• Metachromatic Leukodystrophy Market Research Report: https://www.delveinsight.com/report-store/metachromatic-leukodystrophy-mld-market
• Neuroprosthetics Market: https://www.delveinsight.com/report-store/neuroprosthetics-market-market
Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/consulting/pipeline-assessment-services
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Obsessive Compulsive Disorder Pipeline Analysis 2024: FDA Approvals, Clinical Trials, Therapies, Mechanism of Action, Route of Administration by DelveInsight here
News-ID: 3720464 • Views: …
More Releases from DelveInsight Business Research
Von Willebrand Disease Market Insights Highlight Expanding Outlook Till 2034, De …
DelveInsight's "Von Willebrand Disease Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Von Willebrand Disease, historical and forecasted epidemiology as well as the Von Willebrand Disease market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Von Willebrand Disease market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Von Willebrand Disease…
Global Artificial Kidney Market to reach USD 6.09 billion by 2032 at a CAGR of 1 …
According to DelveInsight's analysis, The growing demand for artificial kidneys is primarily fueled by the increasing prevalence of kidney failure and end-stage renal disease (ESRD), alongside a rising incidence of contributing factors such as diabetes, hypertension, and an aging global population. These trends are driving the need for advanced and efficient renal care technologies. Moreover, the expanding preference for home-based dialysis solutions, combined with continuous technological innovations and frequent product…
Global Bladder Scanners Market to grow at a CAGR of 6.12% by 2032, Evaluates Del …
According to DelveInsight's analysis, The growing prevalence of urinary disorders such as incontinence, urinary retention, and overactive bladder especially among the aging population continues to drive demand for bladder scanners. The increasing preference for non-invasive and efficient diagnostic tools is further propelling market growth, as bladder scanners provide a safe, quick, and accurate alternative to traditional catheterization. Their expanding use across hospitals, clinics, and home care settings highlights their clinical…
Global Transdermal Drug Delivery Devices Market to reach USD 121,798.76 million …
According to DelveInsight's analysis, The rising incidence of chronic diseases, along with the growing adoption of advanced third-generation transdermal drug delivery systems, is substantially driving the global market's growth.
DelveInsight's "Transdermal Drug Delivery Devices Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Transdermal Drug Delivery Devices…
More Releases for Obsessive
Emerging Trends Influencing The Growth Of The Obsessive-Compulsive Disorder Mark …
Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
How Big Is the Obsessive-Compulsive Disorder Market Size Expected to Be by 2034?
The market size of obsessive-compulsive disorder has seen a robust increase in recent times. The sector is projected to progress from $0.62 billion in 2024 to $0.67 billion in 2025, boasting a compound annual growth rate (CAGR) of 8.64%. The historic…
Obsessive Compulsive Disorder Market is tend to be around 10.2%, Size, Trends
Obsessive compulsive disorder is a type of mental illness characterized by repeated unreasonable thoughts and uncontrollable fears resulting in repetitive action or activity by a person. The obsessive-compulsive usually induces individual to throws themselves into particular thought or fear. There are common obsessions associated with it such as contamination, sexual, violent, identity, responsibility and many more.
View Detailed Report" https://www.databridgemarketresearch.com/reports/global-obsessive-compulsive-disorder-market
The global obsessive compulsive disorder market is expected to witness significant growth…
Obsessive Compulsive Disorder Drugs Market to Witness Robust Expansion by 2029
Obsessive Compulsive Disorder Drugs Market is anticipated to grow at a significant CAGR during the forecast period. The major factors that are propelling market growth include increasing R&D investment and a rise in clinical trials by market players, which are expected to fuel the market growth during the forecast period. Obsessive-compulsive disorder (OCD) refers to an anxiety disorder that is characterized by unreasonable and uncontrollable thoughts and fears leading an…
Obsessive Compulsive Disorder (OCD) - Drug Pipeline Landscape, 2022
Global Obsessive Compulsive Disorder Market report from Global Insight Services is the single authoritative source of intelligence on Obsessive Compulsive Disorder market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories,…
Obsessive Compulsive Disorder (OCD) - Drug Pipeline Landscape, 2022
New York, Global Insight Services have recently published a report on Obsessive Compulsive Disorder (OCD) - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.
Read more about Obsessive Compulsive Disorder (OCD) - Drug Pipeline Landscape here: https://www.globalinsightservices.com/reports/obsessive-compulsive-disorder-ocd-drug-pipeline-landscape-2022/
Obsessive-compulsive disorder (OCD) is a common, chronic, and long-lasting disorder in which a person experiences uncontrollable, reoccurring thoughts ("obsessions") and/or…
Obsessive-Compulsive Disorder Market : Technological Advancements, Evolving Indu …
Global Obsessive Compulsive Disorder Market: Regional Outlook
Geographically, the market for obsessive-compulsive disorder (OCD) has been segmented into North America, Europe, Asia-Pacific and Rest of the World (RoW). North America was the largest regional market in 2013, followed by Europe, Asia-Pacific and Rest of the World (RoW). One of the major factors responsible for North America’s leading position in this particular market is well established health coverage in the region and…
